Tomasz Mirski

Tomasz Mirski

Auto-generated profile, based on publicly available information

Tomasz Mirski

Biological Threat Identification and Countermeasure Centre of the Military Institute of Hygiene and Epidemiology, Puławy, Poland.

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
TMTomasz Mirski
Tomasz Mirski
MLMizak Lidia
Mizak Lidia
ANAleksandra Nakonieczna
Aleksandra Nakonieczna
RGRomuald Gryko
Romuald Gryko
The antibiotic resistance in many pathogenic bacteria has become a major clinical problem, therefore, the necessity arises to search for new therapeutic strategies. The most promising solution lies in bacteriophages, phage endolysins and antimicrobial peptides. The aim of this study is to review...

7 June 2017 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
TMTomasz Mirski
Tomasz Mirski
MNMarcin Niemcewicz
Marcin Niemcewicz
MBMichał Bartoszcze
Michał Bartoszcze
RGRomuald Gryko
Romuald Gryko
AMAleksander Michalski
Aleksander Michalski
The emergence of resistance in microorganisms on a global scale has made it necessary to search for new antimicrobial factors. Antimicrobial peptides (AMPs) seem to meet these expectations. AMPs are produced by bacteria, viruses, plants, and animals, and may be considered as a new class of drugs...

1 May 2015 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JSJoanna Stefańska
Joanna Stefańska
Michał AntoszczakMichał Antoszczak
Michał Antoszczak
Karolina StępieńKarolina Stępień
Karolina Stępień
MBMichał Bartoszcze
Michał Bartoszcze
TMTomasz Mirski
Tomasz Mirski
AHAdam Huczyński
Adam Huczyński

1 December 2014 in Veterinary Microbiology
Verified
Journal Article
Open access
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
PCPiotr Cieślik
Piotr Cieślik
TMTomasz Mirski
Tomasz Mirski
JGJerzy Gaweł
Jerzy Gaweł
AMAleksander Michalski
Aleksander Michalski
JKJanusz Kocik
Janusz Kocik
Coxiella burnetii is the etiologic agent of Q fever. It may occur as two different morphological forms, a large cell variant (LCV) and a small cell variant (SCV). The SCV is characterized by unique resistance to physical and chemical factors and may survive in the environment for many months. The objective of this study was to examine environmental samples for the presence of C. burnetii using real-time PCR in areas where Q fever was previously reported and in randomly selected animal farms where Q fever was not reported. The samples were collected in the following provinces in Poland: Lublin, Subcarpathian and Masovian. Monitoring was performed with real-time PCR and serological methods. Of the 727 environmental samples, 33 (4.54%) contained the multi-copy insertion sequence IS1111, which is specific for C. burnetii. Subsequently, the presence of C. burnetii antibodies was determined using serological tests in selected herds in which positive genetic results were obtained. Serological analyses of 169 serum samples using CFT and ELISA were performed on Polish black-and-white Holstein-Friesian cows and one cow imported from Denmark. Using the CFT method, 11 samples were positive for phase I antibodies and six were positive for phase II antibodies. Moreover, in two cases, the presence of antibodies specific for both phase I and phase II antigens of C. burnetii was detected. However, of the 169 examined serum samples, 20 were positive by ELISA test, of which six were also positive by CFT. Additionally, multi spacer typing (MST) of isolated C. burnetii strains was performed. The MST results identified two new genotypes in Poland, ST3 and ST6. The results indicate that continued research regarding spread of this pathogen within a country is necessary.

1 January 2015 in Folia Biologica
Verified
Journal Article
Open access
PDF file
PCP. Cieślik
P. Cieślik
JKJ. Knap
J. Knap
MKM. Kołodziej
M. Kołodziej
TMT. Mirski
T. Mirski
JJJ. Joniec
J. Joniec
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
Bacillus anthracis is a spore-forming, Grampositive microorganism. It is a causative agent of anthrax, a highly infectious disease. It belongs to the “ Bacillus cereus group”, which contains other closely related species, including Bacillus cereus , Bacillus thuringiensis , Bacillus mycoides , Bacillus weihenstephanensis , and Bacillus pseudomycoides . B. anthracis naturally occurs in soil environments. The BA5345 genetic marker was used for highly specific detection of B. anthracis with TaqMan probes. The detection limit of a real-time PCR assay was estimated at the level of 16.9 copies (CI 95% - 37.4 to 37.86, SD = 0.2; SE = 0.118). Oligonucleotides designed for the targeted sequences (within the tested locus) revealed 100 % homology to B. anthracis strain reference sequences deposited in the database (NCBI) and high specificity to all tested B. anthracis strains. Additional in silico analysis of plasmid markers pag and cap genes with B. anthracis strains included in the database was carried out. Our study clearly indicates that the BA5345 marker can be used with success as a chromosomal marker in routine identification of B. anthracis ; moreover, detection of plasmid markers indicates virulence of the examined strains.

4 December 2015 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
TMTomasz Mirski
Tomasz Mirski
MBMichał Bartoszcze
Michał Bartoszcze
ABAgata Bielawska-Drózd
Agata Bielawska-Drózd
RGRomuald Gryko
Romuald Gryko
JKJanusz Kocik
Janusz Kocik
KCKrzysztof Chomiczewski
Krzysztof Chomiczewski
Both the known biological agents that cause infectious diseases, as well as modified (ABF-Advanced Biological Factors) or new, emerging agents pose a significant diagnostic problem using previously applied methods, both classical, as well as based on molecular biology methods. The latter, such as PCR and real-time PCR, have significant limitations, both quantitative (low capacity), and qualitative (limited number of targets). The article discusses the results of studies on using the microarray method for the identification of viruses (e.g. Orthopoxvirus group, noroviruses, influenza A and B viruses, rhino- and enteroviruses responsible for the FRI (Febrile Respiratory Illness), European bunyaviruses, and SARS-causing viruses), and bacteria (Mycobacterium spp., Yersinia spp., Campylobacter spp., Streptococcus pneumoniae, Salmonella typhi, Salmonella enterica, Staphylococcus aureus, Neisseria meningitidis, Clostridium difficile , Helicobacter pylori), including multiple antibiotic-resistant strains. The method allows for the serotyping and genotyping of bacteria, and is useful in the diagnosis of genetically modified agents. It allows the testing of thousands of genes in one experiment. In addition to diagnosis, it is applicable for gene expression studies, analysis of the function of genes, microorganisms virulence, and allows the detection of even single mutations. The possibility of its operational application in epidemiological surveillance, and in the detection of disease outbreak agents is demonstrated.